合并符合新诊断标准的左束支阻滞的慢性心力衰竭患者应用心脏再同步化治疗的疗效分析
2016-07-19汤雪柏徐伟李晓宏张宁
汤雪柏,徐伟,李晓宏,张宁
合并符合新诊断标准的左束支阻滞的慢性心力衰竭患者应用心脏再同步化治疗的疗效分析
汤雪柏,徐伟,李晓宏,张宁
摘要
目的:分析慢性心力衰竭患者合并符合新诊断标准的左束支阻滞(LBBB)(真性LBBB)能否从心脏再同步化治疗(CRT)中更能获益。
方法:研究入选2005-06至2013-05接受CRT的19例患者,依据术前体表心电图QRS波的形态,符合新诊断标准即为真性LBBB组(n=13),符合传统诊断标准即为假性LBBB组(n=6);比较所有入选患者CRT术前与术后左心室射血分数(LVEF)、 左心室舒张末内径(LVEDD)、QRS波时限(QRSd)及心室间机械延迟时间(IVMD);同时比较两组患者术后LVEF、LVEDD、QRSd、IVMD、16节段达最小收缩末容积时间标准差(Tmsv16-SD)及16节段达最小收缩末容积时间的最大差值(Tmsv16-Dif)有无差异。
结果:两组患者在CRT术后的LVEF、LVEDD、IVMD及QRSd均较术前有明显的改善;而且与假性LBBB组比,真性LBBB组的LVEDD[(5.95±0.72)mm vs (7.13±0.78) mm,P<0.01]、IVMD[(22.45±8.00)ms vs (27.63±13.09)ms,P<0.01]及QRSd[(140.38±5.80)ms vs (153.68±14.38)ms,P<0.01]改善更明显;术后两组患者的Tmsv16-SD、Tmsv16-Dif及LVEF的差异均无统计学意义。
结论:合并真性LBBB和假性LBBB的心力衰竭患者均能从CRT中获益,合并真性LBBB的心力衰竭患者获益更明显。
关键词 心脏再同步化治疗;心力衰竭;左束支阻滞
Objective: To analyze the effect of cardiac resynchronization therapy (CRT) in patients with chronic heart failure (CHF) combining left bundle branch block (LBBB) conformed to new diagnostic standard.
Methods: A total of 19 CHF patients who received CRT in our hospital from 2005-06 to 2013-05 were studied. The patients were divided into 2 groups: True LBBB group, n=13 patients conformed to new diagnostic standard and False LBBB group, n=6 patients conformed to traditional diagnostic standard. Pre- and Post-operative LVEF, LVEDD, QRS duration (QRSd) and IVMD were compared in all patients; post-operative LVEF, LVEDD, QRSd, IVMD and Tmsv16-SD, Tmsv16-Dif were compared between 2 groups.
Results: The post-operative LVEF, LVEDD, QRSd and IVMD were improved than pre-operative condition in both groups. Compared with False LBBB group, the improvements were more obvious in True LBBB group as LVEDD by mm (5.95±0.72 vs 7.13±0.78), IVMD by ms (22.45±8.00 vs 27.63±13.09), and QRSd by ms (140.38±5.80 vs 153.68±14.38), allP<0.01. The post-operative LVEF and Tmsv16-SD, Tmsv16-Dif were similar between 2 groups.
Conclusion: CHF patients combining either true or false LBBB could be benefit from CRT, while the patients with true LBBB may receive better clinical outcomes from CRT.
Key words Cardiac resynchronization therapy; Chronic congestive heart failure; Left bundle branch block
(Chinese Circulation Journal, 2016,31:345.)
心脏再同步化治疗(CRT)能够改善慢性心力衰竭患者生活质量,降低全因死亡率及再住院率,但近30%患者在CRT术后无反应性[1-3]。因此,提高CRT后患者的反应性成为目前研究的热点,而COMPANION、CARE-HF、MADIT-CRT、RAFT等研究结果显示左束支阻滞(Left Bundle Branch Block,LBBB)是预测CRT术后能否获益最重要影响因素[4-7]。最近,Strauss等[8]推荐了新的LBBB诊断标准,V1、V2导联呈QS型或rS型;V1、V2、V5、V6、I、aVL六个导联中必须有2个以上导联QRS波形态中间有顿挫或者切迹;男性QRS波时限(QRSd)≥140 ms,女性≥130 ms。……
